AVITA Medical Plans Third Quarter 2025 Financial Announcement
AVITA Medical, Inc. (NASDAQ: RCEL), a frontrunner in therapeutic acute wound care, is set to unveil its financial results for the third quarter of 2025. This significant event is scheduled to take place after the U.S. financial markets close on Thursday, November 6, 2025. As a leading player in the industry, AVITA Medical is dedicated to improving patient outcomes by delivering innovative solutions that foster rapid recovery from wounds.
Conference Call and Webcast Details
Following the financial announcement, the company will hold a conference call and webcast to discuss the results. The event will take place the same day at 1:30 PM Pacific Time. For international stakeholders, the broadcast is set for Friday, November 7, 2025, at 8:30 AM Australian Eastern Daylight Time. This session presents a prime opportunity for investors and analysts to gain insights directly from the company's management team.
How to Access the Webcast
Individuals interested in participating can access the live stream through the Events & Presentations section of the AVITA Medical website at ir.avitamedical.com. For those wishing to join via telephone, prior registration is necessary to obtain dial-in information and a unique PIN. This can be accomplished through a simple registration link provided by the company.
Insights into AVITA Medical's Comprehensive Product Offerings
AVITA Medical is at the forefront of advancing wound care technologies, and its flagship product, the RECELL System, is pivotal in its portfolio. This innovative system, recognized by the U.S. Food and Drug Administration, is designed to expedite healing for patients suffering from thermal burn and trauma wounds. By utilizing the patient’s own skin cells, RECELL creates a unique Spray-On Skin™ Cells solution that enhances clinical outcomes significantly.
Global Market Expansion
In addition to its U.S. offerings, the RECELL System has gained approval in international markets, allowing it to be used effectively for various skin healing applications. This includes regulatory clearances in European countries, along with Australia and Japan. This expansion showcases AVITA Medical’s commitment to making its leading-edge technologies available to a wider patient population across the globe.
Understanding the Company’s Mission and Vision
AVITA Medical's core mission focuses on delivering transformative healthcare solutions to patients. They aim to optimize patient recovery, ensuring that each individual receives the best possible care through state-of-the-art treatment options. With a team dedicated to excellence and innovation, the company continues to explore avenues for growth, all while maintaining its commitment to patient care.
Contact Information for Investors and Media
For those seeking additional insights about the company or its upcoming financial results, AVITA Medical has appointed Ben Atkins as the primary contact for media and investor inquiries. He can be reached by phone at +1-805 341 1571. For specific inquiries, parties can also reach out via email at investor@avitamedical.com or media@avitamedical.com.
Frequently Asked Questions
What is the purpose of AVITA Medical's upcoming financial results announcement?
The announcement will provide insights into the company’s financial performance for Q3 2025, highlighting revenue growth, expenses, and future outlook.
How can I access the conference call for the financial results?
You can access the conference call by visiting the AVITA Medical website under the Events & Presentations section. Participants can join via live webcast or telephone.
What are the main products offered by AVITA Medical?
AVITA Medical’s primary product is the RECELL System, which is used for creating Spray-On Skin™ Cells for treating burns and other trauma wounds.
Where is AVITA Medical expanding its market presence?
The company has expanded its market reach into international regions, including Europe, Australia, and Japan, where the RECELL System is now approved for various therapeutic applications.
How can I get in touch with AVITA Medical's investor relations?
You can contact Ben Atkins directly via phone or through the provided email addresses for investor inquiries or further information about the company.
